Download Now: Precision May Events Calendar
The May Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
Access90: Katherine Ka Wan
With the MHRA becoming the standalone regulator of medicines in Great Britain, Precision research aims to shed light on market access in the post-Brexit era, as well as key implications for manufacturers. In this Access90, Precision's Katherine Ka Wan Leong discusses two research posters the PRECISION team will be presenting at ISPOR US this year focusing on the UK access landscape.
Download Now: Precision April Events Calendar
The April Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
On Demand: Cell and Gene Therapies – How High Can Prices Go?
This ON24 webinar will discuss how cell and gene therapies can be justifiably priced at different levels. We will explore just how high they can extend and also how we can collectively ensure that patients can access these innovations when they are needed. This discussion will be led by David Carr: Senior Director, Global Pricing and Market Access (PRECISIONadvisors), Richard Macaulay: SVP, Global Pricing and Market Access (PRECISIONadvisors).
Article: The Future of Gene Therapies: Three Trends
Since the first gene therapy procedure more than 30 years ago, the field has seen significant advances and development, but also setbacks and issues. What is the future direction for gene therapies? Precision's Phil Cyr, Richard Macaulay and Andy Kinley identify three future trends and how they might impact safety, manufacturing development, and reimbursement and payment.
What you need to know about key stakeholders and P&MA dynamics in Chile for 2023 and beyond
Latin America is a ripe market for pharma, with large populations and significant unmet needs. Yet the political landscape and fragmented healthcare systems call for expertise. Get the full LatAm brief (all 7 parts) from PRECISIONadvisors’ regional authorities.
What you need to know about key stakeholders and P&MA dynamics in Chile for 2023 and beyond
Across Chile, the public is demanding changes in the healthcare system. What does that mean for pharma? PRECISIONadvisors experts explain in this free brief (part 6 of 7).
Download Now: Precision March Events Calendar
The March Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
What you need to know about key stakeholders and P&MA dynamics in Colombia for 2023 and beyond
Colombia is focused on providing broad, equitable access to healthcare—but how will that impact pharma? PRECISIONadvisors experts share their insights in this free brief (part 5 of 7).
What you need to know about key stakeholders and P&MA dynamics in Argentina for 2023 and beyond
Argentina has a large pharma market, a high percentage of GDP spent on healthcare—and aggressive hyperinflation. What does that mean for pharma? Download this free brief (part 4 of 7) by @PRECISIONadvisors experts.
